Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
538.00
+5.00 (0.94%)
Aug 21, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $612.59. The average 1-year stock price forecast is 13.86% higher than the current stock price, while the lowest is $520.00 (-3.35%) and the highest is $765.30 (+42.25%).
Price Target: $612.59 (+13.86%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 15 | 15 | 15 | 16 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 18 | 18 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $611.60 → $624.00 | Buy | Maintains | $611.60 → $624.00 | +15.99% | Aug 21, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $642.00 | Buy | Maintains | $642.00 | +19.33% | Aug 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $550.00 → $630.00 | Buy | Maintains | $550.00 → $630.00 | +17.10% | Aug 20, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $765.30 | Buy | Maintains | $765.30 | +42.25% | Aug 20, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $507.11 → $642.29 | Buy | Maintains | $507.11 → $642.29 | +19.38% | Aug 19, 2026 |
Financial Forecast
Revenue This Year
2.52B
from 2.06B
Increased by 22.33%
Revenue Next Year
4.46B
from 2.52B
Increased by 77.00%
EPS This Year
-0.09
from -1.04
EPS Next Year
3.55
from -0.09
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.